Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

280 HYDROXYUREA
Xerosis (1–10%)
(2004): Zargari O+, Pediatr Dermatol 21(6), 633
(2002): Kumar B+, Clin Exp Dermatol 27(1), 8
(2001): Chaine B+, Arch Dermatol 137, 467 (6 cases)
(1995): Weber L+, Hautarzt (German) 46, 717
(1989): Richard M+, JAmAcadDermatol21, 797 (passim)
(1984): Sigal M+, Ann Dermatol Venereol (French) 111, 895
Mucosal
Glossitis
(2001): Vassallo C+, Clin Exp Dermatol 26(2), 141
Mucocutaneous eruption
(2002): Kumar B+, Clin Exp Dermatol 27(1), 8
Oral lesions
Oral pigmentation (10%)
(1993): Brincker H+, Cancer Chemother Pharmacol 32, 496
(1992): Breathnach SM+, Adverse Drug Reactions and the Skin
Blackwell, Oxford, 303 (passim)
(1989): Richard M+, JAmAcadDermatol21, 797 (passim)
Tongue pigmentation (